Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-11-19 | Amended | $15,000,004 | $12,700,004 | Equity Only | 06b | SEC link |
| 2022-02-02 | New | $2,300,000 | $2,300,000 | Equity Only | 06b | SEC link |
| 2019-11-01 | New | $1,800,000 | $1,800,000 | Equity Only | 06b | SEC link |
| 2017-01-19 | Amended | $2,207,069 | $165,000 | Equity Only | 06b | SEC link |
| 2016-08-18 | New | $2,042,069 | $2,042,069 | Equity Only | 06b | SEC link |
| 2015-10-20 | New | $320,192 | $320,192 | Equity Only | 06b | SEC link |
| 2015-06-29 | New | $70,000 | $70,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Robert Hallenbeck | Director |
| Michael J. Hennessy, Jr. | Director |
| David Narrow | Director, Executive |
| Bill Niland | Director |
| Devin O'brien Coon | Director, Executive |
| Jerry Prince | Director |
| John Rappe | Executive |